My Spouse Works for the Drug Company We’re About to Add to the Formulary. I Can Stay Objective — Do I Need to Say Anything?

Quick Answer

Do I have to disclose a conflict of interest if I’m sure I can stay objective?

Yes. A conflict of interest is about the situation, not your integrity — a household financial interest in a vendor whose products you help select must be disclosed and managed (usually by recusal), regardless of how objective you believe you are. Undisclosed financial conflicts in healthcare purchasing and prescribing can also increase exposure under the Anti-Kickback Statute and the Stark Law.

The duty is to disclose and step back — not to self-certify your own objectivity. See more healthcare scenarios.

Pressure Type: Divided Loyalty

Two real loyalties pull at once — to sound clinical and financial judgment for the system, and to a spouse whose livelihood is tied to the supplier. The trap is believing the second doesn’t touch the first. Divided loyalty rarely announces itself; it just makes “I can be objective” feel like enough.

1. Say nothing and vote.

The clinical merits are real; the connection is irrelevant. Why it fails: a household financial interest in a vendor under review is a textbook conflict that must be disclosed. Voting on it in an undisclosed manner is a violation — regardless of the drug’s merits — and it exposes the decision and the system to Anti-Kickback and Stark scrutiny.

2. Mention it casually, but still vote.

Note the connection, then participate anyway. Why it fails: disclosure without recusal leaves the conflicted person influencing the very decision at issue. The point of disclosure is to enable management — usually stepping out of the discussion and the vote — not to paper over continued participation.

3. Disclose in writing and recuse.

Disclose the relationship in writing before the matter is taken up, and step out of the discussion and the vote. Why it works: see below.

The Right Call

For Dr. Cole: Choice 3 — disclose in writing and recuse.

Dr. Cole discloses the relationship in writing before the matter is taken up and recuses from both the discussion and the vote. The clinical case can still be made by others on its merits. The conflict was never about Dr. Cole’s honesty — it’s that a person with a household stake in the outcome shouldn’t be the one shaping or casting the decision. Disclosure plus recusal protects the patient, the formulary’s integrity, the system, and Dr. Cole.

The conflict feels like an accusation.

Being told to step back can feel like being called dishonest — but a conflict is structural. It’s about position, not character, and recusing is the professional move, not an admission.

The clinical case really may be strong.

When the right answer and the conflicting interest point the same way, disclosure feels pointless. It isn’t — the process has to be clean, independent of the outcome, or no one can trust the outcome.

“Just objectivity” is unmeasurable.

No one can verify their own freedom from bias, which is exactly why the rule relies on disclosure and recusal rather than self-assessment.

“My spouse’s job has nothing to do with my medical judgment.”

Maybe not — but that’s not the test, and it’s not yours to certify. The rules don’t ask whether you can stay objective; they ask whether someone with a household stake in the outcome should be deciding it. The answer is no, and disclosure plus recusal is how you honor that.

Do I have to disclose if I’m sure I can be objective?

Yes. Disclosure obligations turn on the existence of the interest, not your confidence in your own neutrality. The situation creates the duty, regardless of intent.

Isn’t disclosure enough — why recuse?

Disclosure lets the conflict be managed; for a direct financial stake in a decision you’d vote on, management usually means recusal, so the conflicted person isn’t shaping the outcome.

How does this connect to Anti-Kickback or Stark?

Financial relationships that influence healthcare purchasing, referrals, or prescribing can trigger those laws. Transparent disclosure and recusal help keep decisions defensible.

How to Use This in Training

Run it in 10–15 minutes with committee members, physician leaders, and supply-chain staff. Read the situation, then ask: “Whose job is it to decide whether you can be objective?” The answer — not yours — is the whole lesson.

Close on the habit: disclose in writing, recuse from discussion and vote, and keep the process clean regardless of the merits. Available as a manager-led Decision Brief™.

HIPAA — Patient Privacy

A Patient Everyone’s Talking About Just Got Admitted. Is One Look Really a Problem? →

Sunshine Act — Gifts

The Drug Rep Wants to Take the Whole Team to Dinner. Does It Really Get Reported? →

False Claims Act — Billing

I’m Told to Bill Every Visit a Level Higher. Is That Just Aggressive Coding? →